EP 0927026 A1 19990707 - PHARMACEUTICAL COMPOSITIONS CONTAINING AMISULPRIDE AND THEIR THERAPEUTIC APPLICATIONS
Title (en)
PHARMACEUTICAL COMPOSITIONS CONTAINING AMISULPRIDE AND THEIR THERAPEUTIC APPLICATIONS
Title (de)
AMISULPRIDE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND IHRE THERAPEUTISCHE VERWENDUNGEN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE L'AMISULPRIDE ET LEURS APPLICATIONS THERAPEUTIQUES
Publication
Application
Priority
- FR 9701633 W 19970917
- FR 9611391 A 19960918
Abstract (en)
[origin: FR2753376A1] The invention concerns a pharmaceutical composition, particularly to be orally administered, containing a lipophilic phase and at least one active principle consisting of amisulpride, one of its laevo-rotary and dextro-rotary isomers or an amisulpride derivative selected among its additive salts with phamaceutically acceptable acids, its quaternary ammonium salts, its oxides and their leavo-rotary and dextro-rotary isomers. The invention has useful therapeutic applications.
IPC 1-7
IPC 8 full level
A61K 9/107 (2006.01); A61K 9/48 (2006.01); A61K 9/66 (2006.01); A61K 31/40 (2006.01); A61P 25/18 (2006.01)
CPC (source: EP US)
A61K 9/1075 (2013.01 - EP US); A61K 9/4858 (2013.01 - EP US); A61K 31/40 (2013.01 - EP US); A61P 25/18 (2017.12 - EP)
Citation (search report)
See references of WO 9811881A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
FR 2753376 A1 19980320; FR 2753376 B1 19981016; AU 4305897 A 19980414; AU 729707 B2 20010208; CA 2265894 A1 19980326; EP 0927026 A1 19990707; JP 2001501192 A 20010130; US 6069165 A 20000530; WO 9811881 A1 19980326; ZA 978383 B 19980324
DOCDB simple family (application)
FR 9611391 A 19960918; AU 4305897 A 19970917; CA 2265894 A 19970917; EP 97919108 A 19970917; FR 9701633 W 19970917; JP 51434298 A 19970917; US 25468699 A 19990316; ZA 978383 A 19970917